- Investing Ideas
- /
- Household Healthcare Sector
Household Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Devonian Health Group
Market Cap: CA$26.7m
Engages in the development of botanical drugs.
GSD
CA$0.18
7D
12.5%
1Y
-7.7%
Retractable Technologies
Market Cap: US$19.4m
Designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
RVP
US$0.65
7D
-9.9%
1Y
-31.0%
PetVivo Holdings
Market Cap: US$19.4m
A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals.
PETV
US$0.80
7D
4.0%
1Y
31.1%
DiagnosTear Technologies
Market Cap: CA$26.5m
An ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases.
DTR
CA$0.45
7D
60.7%
1Y
n/a
Elite Health Systems
Market Cap: US$19.3m
Through its subsidiaries, develops a business to provide Medicare Advantage plans and related services in California and Nevada.
USNU
US$0.90
7D
4.7%
1Y
30.4%
Greenway Greenhouse Cannabis
Market Cap: CA$26.4m
Engages in the cultivation, processing, and sale of dried cannabis.
GWAY
CA$0.20
7D
5.3%
1Y
-39.4%
Treatment.com AI
Market Cap: CA$26.4m
Treatment.Com International Inc. provides personalized health care information services in Canada.
TRUE
CA$0.46
7D
-3.2%
1Y
-9.0%
Polarean Imaging
Market Cap: UK£14.2m
Operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States.
POLX
UK£0.012
7D
-4.1%
1Y
-6.0%
Lipocine
Market Cap: US$19.2m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
LPCN
US$3.58
7D
-10.3%
1Y
-48.0%
Third Age Health Services
Market Cap: NZ$31.9m
Provides health care services for residential aged care facilities, private hospitals, and secure dementia in New Zealand.
TAH
NZ$3.20
7D
3.2%
1Y
131.9%
BioVie
Market Cap: US$19.0m
A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease.
BIVI
US$1.03
7D
0%
1Y
-77.3%
HOOKIPA Pharma
Market Cap: US$18.9m
A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.
HOOK
US$1.51
7D
-3.2%
1Y
-81.1%
Ananda Pharma
Market Cap: UK£14.0m
Invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally.
ANA
UK£0.0032
7D
0%
1Y
44.4%
Cyclacel Pharmaceuticals
Market Cap: US$18.8m
A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.
CYCC
US$1.45
7D
-27.5%
1Y
-95.6%
Elevation Oncology
Market Cap: US$18.7m
An oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.
ELEV
US$0.32
7D
11.8%
1Y
-91.8%
ABVC BioPharma
Market Cap: US$18.7m
A clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.
ABVC
US$1.15
7D
-22.3%
1Y
23.0%
Nyrada
Market Cap: AU$28.5m
A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.
NYR
AU$0.14
7D
28.6%
1Y
117.7%
Cognition Therapeutics
Market Cap: US$18.4m
A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
CGTX
US$0.30
7D
-8.7%
1Y
-88.4%
Clever Culture Systems
Market Cap: AU$28.3m
Engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany.
CC5
AU$0.016
7D
-11.1%
1Y
-11.1%
Adagio Medical Holdings
Market Cap: US$18.3m
A developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.
ADGM
US$1.19
7D
0.8%
1Y
-89.5%
BCAL Diagnostics
Market Cap: AU$27.8m
A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.
BDX
AU$0.076
7D
-7.3%
1Y
-30.9%
C21 Investments
Market Cap: CA$24.8m
An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.
CXXI
CA$0.21
7D
2.4%
1Y
-53.8%
Stella Diagnostics
Market Cap: US$18.0m
A research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases.
SLDX
US$0.049
7D
0%
1Y
-38.0%
ImmuPharma
Market Cap: UK£13.3m
A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.
IMM
UK£0.027
7D
-20.9%
1Y
20.7%
X4 Pharmaceuticals
Market Cap: US$17.9m
A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.
XFOR
US$3.10
7D
6.2%
1Y
-88.6%
Rapid Dose Therapeutics
Market Cap: CA$24.4m
A life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada.
DOSE
CA$0.19
7D
-2.6%
1Y
-20.8%
Aurora Spine
Market Cap: CA$24.0m
Through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada.
ASG
CA$0.31
7D
-3.1%
1Y
21.6%
DIAGNOS
Market Cap: CA$23.9m
Provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally.
ADK
CA$0.23
7D
-2.1%
1Y
-24.2%
Bullfrog AI Holdings
Market Cap: US$17.4m
Through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
BFRG
US$1.85
7D
5.7%
1Y
-37.9%
VYNE Therapeutics
Market Cap: US$17.3m
A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.
VYNE
US$1.04
7D
-14.8%
1Y
-59.7%
WORK Medical Technology Group
Market Cap: US$17.2m
Manufactures and sells medical consumables in the People’s Republic of China and internationally.
WOK
US$0.70
7D
34.8%
1Y
n/a
PharmChem
Market Cap: US$17.2m
Provides PharmChek Sweat Patch that is used to detect drugs of abuse.
PCHM
US$3.70
7D
8.8%
1Y
29.8%
VSee Health
Market Cap: US$17.2m
Provides telehealth care solutions.
VSEE
US$1.09
7D
-1.8%
1Y
-91.9%
Nova Leap Health
Market Cap: CA$23.6m
Provides home and home health care services in the United States and Canada.
NLH
CA$0.27
7D
10.2%
1Y
-10.0%
Gelteq
Market Cap: US$17.0m
Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.
GELS
US$1.80
7D
-5.8%
1Y
n/a
Imunon
Market Cap: US$17.0m
A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.
IMNN
US$1.16
7D
139.7%
1Y
-23.2%